About Us
Serving you.
So you can serve them.
We deliver what you need, when you need it.
Our Mission
Transforming lives challenged with chronic wounds.
Our mission has always been the same:
We are dedicated to transforming lives challenged with chronic wounds.
From day one our founder, Roger Chasteen, set out to remove the friction between care and supply. He’s seen firsthand the positive impact a capable distributor can have on a wound care practice.
For Roger, this is personal.
Our Team
Meet Advanced Medical Administration.
Founder and CEO
Roger Chasteen
With over 30 years of experience in sales, marketing, and corporate communications Roger brings a unique blend of operational insight and mission-driven focus to the wound care industry. His personal connection to the challenges of chronic wound care influenced AMA’s vision: to remove friction between patient care and product supply so providers can do what they do best: serve patients well.
Chief Operating Officer
Jeremy Couey
His focus to create and execute strategy is built on operational excellence and has allowed AMA to scale growth and become a premier national distributor.
Chief Financial Officer
Jason Smith
Jason is a seasoned financial executive with deep expertise in accounting, financial analysis, and operational management. He has played a pivotal role in guiding organizations through business development, strategic planning, mergers and acquisitions, divestitures, and cash flow optimization.
Summer Ross
Director of Operations
Matthew Goelzer, PhD
Director of Biomedical Research
Terry Bonney
National Sales Director
Evan Chasteen
Dir. of Marketing & Talent
Timing. Consistency. Trust.
We bring together professionals passionate about ensuring providers have what they need, when they need it.
We understand distribution complexities.
Every detail matters.
From documentation and Q-codes to product traceability and logistics, our staff is trained in the regulatory and operational requirements that keep ordering, documentation, and delivery smooth and dependable. We stay informed on FDA and CMS updates so providers can rely on accurate, current information.
Want to read more?
From amniotic grafts to other biologics, we connect providers to a diverse selection of advanced wound care products.
With one agreement you’ll have access to a broad portfolio sourced from FDA-registered manufacturers. Our range allows providers to choose products appropriate for their specific care settings under CMS-defined guidelines.
Want to read more?
We believe great service is about consistency and clarity.
From your first order to final delivery, our team is available to answer questions, coordinate logistics, and ensure a smooth process. We prioritize responsiveness, reliability, and accurate communication because behind every shipment is a provider (and a patient) who is depending on it.
Want to read more?
Compliance isn’t a checkbox. It’s part of how we work.
Every process, from sourcing to fulfillment, is built on adherence to federal and industry requirements. We follow industry standards in all distribution practices and ensure our partners have access to transparent, accurate documentation.
Want to read more?
Careers
Join our team.
Frequently Asked
Don’t see your question below? Reach out. Our team is ready and waiting to answer any questions you may have.
How many products do you have at AMA?
Advanced Medical Administration (AMA) offers one of the largest portfolios of amniotic and skin-substitute grafts in the nation, representing multiple FDA-registered manufacturers. Our catalog includes both dehydrated and hydrated placental products, as well as collagen-based and synthetic options. We continually expand our offering each quarter to ensure providers have access to the most clinically advanced options available.
What product is most commonly used?
Every wound is unique, and product selection is always guided by medical necessity and the clinical characteristics of the wound. AMA provides a full spectrum of graft options—including single-layer, dual-layer, tri-layer, and full membrane configurations—so that providers can choose the most appropriate solution for each patient. Our goal is to equip you with the right tools to support consistent, high-quality healing outcomes.
Are your products FDA cleared?
All products distributed through AMA are regulated under Section 361 of the Public Health Service Act and the oversight of the U.S. Department of Health and Human Services (HHS). They are processed by FDA-registered tissue banks that comply with the requirements for human cellular and tissue-based products (HCT/Ps). This ensures each graft meets the highest national standards for safety, quality, and ethical sourcing.